DYAX: Dyax Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DYAX: Dyax Corp.

DYAX 38.41

0.0%

Jan 25 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: idos	5/4/2007 9:07:14 AM
	of 197

Fri May 4 04:39:18 2007 (Dyax Corp.) Dyax Announces the Resignation of Thomas Beck, M.D., President and Chief Operating Officer CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (Nasdaq: DYAX - News) announced today the resignation of Thomas Beck, M.D., as the Company's President and Chief Operating Officer. Dr. Beck will remain with the Company in a consulting capacity. "Tom Beck has played a significant role in building a strong clinical development organization as Dyax moves towards market approval for its lead product candidate. He has helped with the advancement of DX-88 in hereditary angioedema as well as in the positioning of DX-88 for development in the broader cardiothoracic surgery market," stated Henry Blair, Chairman and Chief Executive Officer of Dyax. "We are thankful for Tom's contributions and appreciate his willingness to continue to assist us during a transition period."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next